Literature DB >> 7930746

Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus.

K A Martin1, A K Junker, E E Thomas, M I Van Allen, J M Friedman.   

Abstract

In a group of 21 women counseled after exposure to chickenpox during pregnancy, 4 developed varicella despite initial studies showing that preinfection sera were varicella-zoster virus (VZV)-seropositive by fluorescent anti-membrane antibody, latex agglutination, ELISA, and VZV glycoprotein immunoblot assay. Further investigations showed that 2 of the 4 had low-titer (1/100), low-avidity, VZV-reactive IgG3 antibodies by ELISAs of preinfection sera. After chickenpox, these women developed primary-like serologic responses to VZV. Two women with high-titer (1/1600, 1/3200), high-avidity, IgG1 antibodies showed anamnestic serologic responses after reinfection. The criteria of protective VZV immunity remain ill-defined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930746     DOI: 10.1093/infdis/170.4.991

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.

Authors:  Jennifer A Johnson; Karen C Bloch; Bich N Dang
Journal:  Clin Infect Dis       Date:  2011-01-27       Impact factor: 9.079

Review 2.  Varicella-zoster virus (chickenpox) infection in pregnancy.

Authors:  Ronald F Lamont; Jack D Sobel; D Carrington; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Roberto Romero
Journal:  BJOG       Date:  2011-05-18       Impact factor: 6.531

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  The consistency of shingles and its significance for health monitoring.

Authors:  Douglas M Fleming; Aad Bartelds; Rachel S Chapman; Kenneth W Cross
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 12.434

5.  The challenge of avidity determination in SARS-CoV-2 serology.

Authors:  Georg Bauer; Friedhelm Struck; Patrick Schreiner; Eva Staschik; Erwin Soutschek; Manfred Motz
Journal:  J Med Virol       Date:  2021-02-19       Impact factor: 20.693

Review 6.  The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).

Authors:  Georg Bauer
Journal:  J Med Virol       Date:  2020-07-15       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.